Tokyo Tape
Sign in
← Jmdc

Quarterly report · Q1

4483.TEDINET S100RPCP
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥6.7bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥27.8bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥5.8bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥2.5bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥2.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥5.9bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.0bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥765m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.0bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥759m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥97.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥98.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥63.3bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥31.7bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥34.0bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥65.8bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥64.5bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥31.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥31.2bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥65.9bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥64.5bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥31.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥23.0bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥22.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥4.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥22.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥273m2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥28.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥909m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥32.422023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥13.552022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥31.072023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.692022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥12.732022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio67.5%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio49.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥76m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥76m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥151m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥969m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥919m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥50m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2023-04-01 → 2023-06-30¥87m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2023-04-01 → 2023-06-30¥4.5bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2023-04-01 → 2023-06-30¥4.5bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥25m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥448m
—segment totalrevenue2023-04-01 → 2023-06-30¥6.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥6.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥76m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥90m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥910m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥869m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥41m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥47m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2022-04-01 → 2022-06-30¥1.1bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥439m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥58m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 632
ItemContextValueUnit
Income taxes payable cl IFRSPrior1YearInstant1201000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant540000000JPY
Contract liabilities cl IFRSPrior1YearInstant2066000000JPY
Contract liabilities cl IFRSCurrentQuarterInstant2214000000JPY
Other current liabilities cl IFRSPrior1YearInstant1317000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant1132000000JPY
Total current liabilities IFRSPrior1YearInstant12216000000JPY
Total current liabilities IFRSCurrentQuarterInstant10564000000JPY
Borrowings ncl IFRSPrior1YearInstant11935000000JPY
Borrowings ncl IFRSCurrentQuarterInstant11680000000JPY
Lease liabilities ncl IFRSPrior1YearInstant6623000000JPY
Lease liabilities ncl IFRSCurrentQuarterInstant6780000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant322000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant126000000JPY
Provisions ncl IFRSPrior1YearInstant692000000JPY
Provisions ncl IFRSCurrentQuarterInstant421000000JPY
Deferred tax liabilities IFRSPrior1YearInstant730000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant724000000JPY
Contract liabilities ncl IFRSPrior1YearInstant1520000000JPY
Contract liabilities ncl IFRSCurrentQuarterInstant1383000000JPY
Non current labilities IFRSPrior1YearInstant21825000000JPY
Non current labilities IFRSCurrentQuarterInstant21117000000JPY
Liabilities IFRSPrior1YearInstant34042000000JPY
Liabilities IFRSCurrentQuarterInstant31682000000JPY
Share capital IFRSPrior1YearInstant23994000000JPY
Share capital IFRSCurrentQuarterInstant24008000000JPY
Capital surplus IFRSPrior1YearInstant27211000000JPY
Capital surplus IFRSCurrentQuarterInstant27225000000JPY
Treasury shares IFRSPrior1YearInstant-2000000JPY
Treasury shares IFRSCurrentQuarterInstant-2000000JPY
Other components of equity IFRSPrior1YearInstant28000000JPY
Other components of equity IFRSCurrentQuarterInstant26000000JPY
Retained earnings IFRSPrior1YearInstant13308000000JPY
Retained earnings IFRSCurrentQuarterInstant14597000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant64539000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant65856000000JPY
Non controlling interests IFRSPrior1YearInstant-14000000JPY
Non controlling interests IFRSCurrentQuarterInstant-14000000JPY
Equity IFRSPrior1YearInstant64524000000JPY
Equity IFRSCurrentQuarterInstant65841000000JPY
Liabilities and equity IFRSPrior1YearInstant98567000000JPY
Liabilities and equity IFRSCurrentQuarterInstant97523000000JPY
Revenue IFRSPrior1YTDDuration5776000000JPY
Revenue IFRSCurrentYTDDuration6698000000JPY
Cost of sales IFRSPrior1YTDDuration2455000000JPY
Cost of sales IFRSCurrentYTDDuration2999000000JPY
Gross profit IFRSPrior1YTDDuration3320000000JPY
Gross profit IFRSCurrentYTDDuration3698000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration2244000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration2570000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass